Uli Chettipally, Sirica Therapeutics - Digital Autism Therapy Using VR and Exercise | LSI USA '25

Sirica Therapeutics is a pioneering biopharmaceutical company focused on developing targeted therapies for rare diseases, utilizing advanced RNA technologies to address unmet patient needs.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Uli Chettipally
Founder, President & CEO, Sirica Therapeutics